Translational Implications for Noncoding RNA in Cancer

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4614-8444-8_11
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Leukemia cell to endothelial cell communication via exosomal miRNAs

  2013cited by this paper
• Down‐regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer

  2012cited by this paper
• Loss of Dicer expression is associated with breast cancer progression and recurrence

  2012cited by this paper
• MiRNA-21

  2012cited by this paper
• Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

  2012cited by this paper
• Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery

  2012cited by this paper
• MicroRNA profiling: approaches and considerations

  2012cited by this paper
• An alternative mode of microRNA target recognition

  2012cited by this paper
• MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

  2012cited by this paper
• miR-34 – a microRNA replacement therapy is headed to the clinic

  2012cited by this paper
• Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies

  2011cited by this paper
• MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

  2011cited by this paper
• Silencing microRNA by interfering nanoparticles in mice

  2011cited by this paper
• Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers

  2011cited by this paper
• MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

  2011cited by this paper
• EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

  2011cited by this paper
• Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche.

  2011cited by this paper
• Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice.

  2011cited by this paper
• Identification of ten serum microRNAs from a genome‐wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis

  2011cited by this paper
• Intercellular nanovesicle‐mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth

  2011cited by this paper
• Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

  2011cited by this paper
• MicroRNA therapeutics in preclinical cancer models.

  2011cited by this paper
• A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer

  2011cited by this paper
• Functional SNP in the microRNA-367 binding site in the 3′UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification

  2011cited by this paper
• The promise of microRNA replacement therapy.

  2010cited by this paper
• Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high‐risk women

  2010cited by this paper
• Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes.

  2010cited by this paper
• Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer

  2010cited by this paper
• Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.

  2010cited by this paper
• MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia

  2010cited by this paper
• MicroRNA-155 Regulates Cell Survival, Growth, and Chemosensitivity by Targeting FOXO3a in Breast Cancer*

  2010cited by this paper
• Predictors of graft and patient survival in subjects undergoing transplantation for hepatitis C virus infection

  2010cited by this paper
• Human tumor virus utilizes exosomes for intercellular communication

  2010cited by this paper
• Causes and consequences of microRNA dysregulation in cancer

  2009cited by this paper
• Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.

  2009cited by this paper
• Regression of murine lung tumors by the let-7 microRNA

  2009cited by this paper
• Ago HITS-CLIP decodes miRNA-mRNA interaction maps

  2009cited by this paper
• Detection of microRNA Expression in Human Peripheral Blood Microvesicles

  2008cited by this paper
• Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells

  2008cited by this paper
• MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.

  2008cited by this paper
• Dicer, Drosha, and outcomes in patients with ovarian cancer.

  2008cited by this paper
• The utility of LNA in microRNA-based cancer diagnostics and therapeutics.

  2008cited by this paper
• Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer

  2008cited by this paper
• LNA-mediated microRNA silencing in non-human primates

  2008cited by this paper
• Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs.

  2008cited by this paper
• Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct.

  2008cited by this paper
• The let-7 microRNA reduces tumor growth in mouse models of lung cancer

  2008cited by this paper
• Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis

  2008cited by this paper
• Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers

  2008cited by this paper
• Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.

  2007cited by this paper
• The let-7 microRNA represses cell proliferation pathways in human cells.

  2007cited by this paper
• Toxicogenomics of drug delivery systems: Exploiting delivery system-induced changes in target gene expression to enhance siRNA activity

  2007cited by this paper
• Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

  2007cited by this paper
• RNAi therapeutics: principles, prospects and challenges.

  2007cited by this paper
• Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

  2007cited by this paper
• Oncomirs — microRNAs with a role in cancer

  2006cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

  2006cited by this paper
• Progress Toward In Vivo Use of siRNAs-II

  2006cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

  2005cited by this paper
• A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

  2005cited by this paper
• Reduced expression of Dicer associated with poor prognosis in lung cancer patients

  2005cited by this paper
• RAS is regulated by the let-7 microRNA family.

  2005cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• Real-time expression profiling of microRNA precursors in human cancer cell lines

  2005cited by this paper
• Silencing of microRNAs in vivo with ‘antagomirs’

  2005cited by this paper
• MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.

  2004cited by this paper
• Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

  2004cited by this paper
• An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues.

  2004cited by this paper
• siRNA function in RNAi: a chemical modification analysis.

  2003cited by this paper
• Stable suppression of tumorigenicity by virus-mediated RNA interference.

  2002cited by this paper
• Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.

  2002cited by this paper
• Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation.

  2000cited by this paper
• Supplementary Figures Supplementary Figure S1. Differential Buoyant Velocity Centrifugation. A. Breast Cancer Cell Lines (1.2-1.6x10 9 ) Were Maintained in Nunc Cell Factories

  year unknowncited by this paper

• Nanorobotics: a promising medical frontier.

  2014cites this paper